首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Psychopharmacology

缩写:PSYCHOPHARMACOLOGY

ISSN:0033-3158

e-ISSN:1432-2072

IF/分区:3.3/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引5566
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Loc M Pham,Andria B Nanney,Jordan Hasting et al. Loc M Pham et al.
Rationale: Opioid-related overdose deaths involving benzodiazepines have increased in recent years, and prior studies have reported that clinically used benzodiazepines can enhance the respiratory-depressant effects of mu...
Nicholas M Russell,Micah D Frier,Marco Bortolato et al. Nicholas M Russell et al.
Rationale: The relationship between alcohol misuse and aggression has long intrigued clinical and preclinical researchers. While acute alcohol use is well known to promote aggression, converging evidence indicates a more ...
Vítor Bruno,Lídia Emmanuela Wiazowski Spelta,Matheus Lujan Pereira et al. Vítor Bruno et al.
Rationale: Ayahuasca is a brew containing the psychedelic compound N,N-dimethyltryptamine (DMT) and β-carbolines, traditionally consumed in indigenous rituals. Recent studies suggest its potential to reduce depression an...
Nina Gregoire,Ethan Klukas,Kimberley Kaseweter et al. Nina Gregoire et al.
Rationale: Ketamine-assisted therapy is emerging as a fast-acting intervention for treatment-resistant depression and anxiety. However, individual response to treatment varies, and little is known about how personality tr...
Sarah A Schoenrock,Christiann H Gaines,Padam Kumar et al. Sarah A Schoenrock et al.
Rationale: Cocaine use disorder (CUD) is a significant health concern that has devastating impacts on affected individuals and society. There are currently no approved therapies to treat CUD due, in part, to significant g...
David A Bender,Sandeep M Nayak,Joshua S Siegel et al. David A Bender et al.
Rationale: Psychedelic treatments are considered to involve unique treatment challenges relative to other psychiatric interventions, though these are typically not explored in detail within clinical trial reports. ...
Ilya D Ionov,Maria D Krasilova,Niсholas P Gorev et al. Ilya D Ionov et al.
Rationale: Tardive dyskinesia (TD), a late onset involuntary repetitive movements, is a complication of antipsychotic therapy. The mechanism of TD development is currently obscure. In TD patients, an increased brain level...
Haotian Ma,Wenrong Tian,Jing Xiao et al. Haotian Ma et al.
The treatment of morphine addiction remains a significant clinical challenge, and the development of novel pharmacotherapies for opioid use disorder (OUD) is imperative. Agmatine, an endogenous neuromodulator, has promising antiaddictive po...
Pierpaolo Congia,Maria Gabriella Brundu Pierpaolo Congia
Rationale: Chronic substance use disrupts autonomic nervous system (ANS) function, altering stress and reward processing. The clinical significance of autonomic responses to alcohol-related stimuli in cocaine use disorder...
Annie Hawks,Mary B Spodnick,Malcolm C Jennings et al. Annie Hawks et al.
Rationale: Affective behavioral effects of kappa-opioid receptor (KOR) stimulation have been found to vary between the rostral and caudal nucleus accumbens (NAc) shell, but this has so far only been demonstrated in males....